October 4, 2012

The Keystone Folding Box Co. has launched a pharmaceutical compliance packaging system that it said was environmentally sustainable, easy to use for elderly people and resistant to tampering by children.

October 3, 2012

Sagent Pharmaceuticals has launched a drug used to treat apnea of prematurity in infants, the drug maker said Wednesday.

October 2, 2012

Two companies have signed a deal to provide access to real-time medication history to healthcare providers.

October 1, 2012

More than 20,000 RxAlly member pharmacies — including independent pharmacies, regional chains and Walgreens — will begin accepting a new federally qualified Medicare Prescription Drug Plan, SmartD Rx, beginning Jan. 1, 2013.

September 28, 2012

Supermarket chain Bi-Lo is adding the generic form of a blood-thinning drug to its generic-discount program.

September 28, 2012

Generic drug maker Mylan has received regulatory approval for a drug used to treat high blood pressure, also known as hypertension, the company said Friday.

September 28, 2012

Keynote speeches by pharmaceutical industry and regulatory leaders got top billing as more than 140 government, healthcare industry, law enforcement and patient advocacy officials gathered to find ways to combat the spread of counterfeit medicines.

September 28, 2012

For the first time in a decade, sales of vaccines declined, Kalorama Information noted in a report released Thursday.

September 27, 2012

More than one-fifth of prescriptions given to children at clinics in Illinois were never filled, according to a new study.

September 27, 2012

Dr. Reddy's Labs has launched a generic drug for treating asthma and allergies, and preventing bronchospasm during exercise, the company said.

September 25, 2012

The generic drug user fee program may have hit a speed bump due to budget problems in Congress, according to published reports.

September 25, 2012

Generic drug maker Watson Labs recalled two lots of a prescription painkiller due to the potential for oversized and overly potent tablets, the company said.

September 24, 2012

The Food and Drug Administration is creating a new task force to support the development of new drugs for bacterial infections, the agency said Monday.

September 24, 2012

McKesson on Monday named Mark Walchirk president of its U.S. pharmaceutical division, effective immediately.

September 24, 2012

Pharmacy staff, law-enforcement officials and loss-prevention personnel can follow updates about pharmacy robberies, burglaries and potential threats in their area through Twitter updates by a drug maker that developed a program to combat pharmacy crime.

September 24, 2012

Generic drug maker Sandoz has launched an authorized generic version of a drug used to treat hypertension.

September 24, 2012

The retail health clinic and urgent care center market currently is worth about $10 billion and is poised for strong growth in the coming years as the shortage of primary care physicians and crowded emergency rooms increasingly move patients to retail sites, according to new data by Marketdata Enterprises, an independent market research publisher.

September 21, 2012

The Food and Drug Administration has approved a blood pressure medication made by Mylan.

September 21, 2012

The Food and Drug Administration has approved a generic drug for motion sickness made by Mylan.

September 20, 2012

Drug maker Dr. Reddy's Labs has launched a generic antibiotic drug, the company said Thursday.

September 18, 2012

A trillion of anything is difficult to wrap one’s head around, whether it’s the number of grains of sand on a beach or stars in the sky. It’s so much easier for the human mind to look at such a quantity as the sum of its parts rather than on the basis of its individual components.


September 18, 2012

It’s a little hard not to say “Oh, how the mighty have fallen” when a retailer announces that it will give away for free what was once the world’s top-selling drug. But for retailers, it also makes good business sense.


September 18, 2012

Over the last few years of DSN’s coverage of the impending patent cliff and how it would affect the generic drug industry, IMS Health VP industry relations Doug Long predicted that the gradual commoditization of primary care drugs — long the lifeblood of generic drug makers — would lead to consolidation of the industry.


September 18, 2012

Generic drug makers Hospira, Sagent Pharmaceuticals and Teva Pharmaceutical Industries have launched generic versions of a chemotherapy drug made by Sanofi, the three companies said last month.